ESMO 2020: Olaparib Improves Overall Survival in Molecular Subset of Advanced, Castration-Resistant Prostate Cancer
Study authors call for implementation of genomic testing in clinical practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.